Aptamer-based proximity labeling guides covalent RNA modification / Daniel Englert, Regina Matveeva, Murat Sunbul, Richard Wombacher and Andres Jäschke
We describe the development of a proximity-induced bio-orthogonal inverse electron demand Diels-Alder reaction that exploits the high-affinity interaction between a dienophile-modified RhoBAST aptamer and its tetramethyl rhodamine methyltetrazine substrate. We applied this concept for covalent RNA labeling in proof-of-principle experiments..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
04 Mar 2021 2021 |
---|---|
Erschienen: |
04 Mar 2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
---|---|
Enthalten in: |
Chemical communications - 57(2021), 28, Seite 3480-3483 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Englert, Daniel, 1992- [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Gesehen am 06.05.2021 |
---|
Umfang: |
4 |
---|
doi: |
10.1039/D1CC00786F |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1757245510 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1757245510 | ||
003 | DE-627 | ||
005 | 20230426114314.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210506s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1039/D1CC00786F |2 doi | |
035 | |a (DE-627)1757245510 | ||
035 | |a (DE-599)KXP1757245510 | ||
035 | |a (OCoLC)1341408425 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Englert, Daniel |d 1992- |e verfasserin |0 (DE-588)1188420569 |0 (DE-627)1667349406 |4 aut | |
245 | 1 | 0 | |a Aptamer-based proximity labeling guides covalent RNA modification |c Daniel Englert, Regina Matveeva, Murat Sunbul, Richard Wombacher and Andres Jäschke |
264 | 1 | |c 04 Mar 2021 | |
300 | |a 4 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 06.05.2021 | ||
520 | |a We describe the development of a proximity-induced bio-orthogonal inverse electron demand Diels-Alder reaction that exploits the high-affinity interaction between a dienophile-modified RhoBAST aptamer and its tetramethyl rhodamine methyltetrazine substrate. We applied this concept for covalent RNA labeling in proof-of-principle experiments. | ||
700 | 1 | |a Matveeva, Regina |e verfasserin |0 (DE-588)1232955167 |0 (DE-627)1757243836 |4 aut | |
700 | 1 | |a Sünbül, Murat |e verfasserin |0 (DE-588)118481189X |0 (DE-627)166370385X |4 aut | |
700 | 1 | |a Wombacher, Richard |e verfasserin |0 (DE-588)1025170946 |0 (DE-627)721363288 |0 (DE-576)252266587 |4 aut | |
700 | 1 | |a Jäschke, Andres |d 1962- |e verfasserin |0 (DE-588)1025112261 |0 (DE-627)751682756 |0 (DE-576)170797481 |4 aut | |
770 | 0 | 8 | |i Supplement |a Englert, Daniel, 1992 - |t Supporting information: Aptamer-based proximity labeling guides covalent RNA modification |d 2021 |g 57(2021), 28, Seite 3480-3483 |w (DE-627)1757254099 |
773 | 0 | 8 | |i Enthalten in |t Chemical communications |d Cambridge : Soc., 1965 |g 57(2021), 28, Seite 3480-3483 |h Online-Ressource |w (DE-627)268759081 |w (DE-600)1472881-3 |w (DE-576)077609867 |x 1364-548X |7 nnns |
773 | 1 | 8 | |g volume:57 |g year:2021 |g number:28 |g pages:3480-3483 |g extent:4 |
856 | 4 | 0 | |u https://doi.org/10.1039/D1CC00786F |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u https://pubs.rsc.org/en/content/articlelanding/2021/cc/d1cc00786f |x Verlag |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_32 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_100 | ||
912 | |a GBV_ILN_101 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_120 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_374 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2007 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2110 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_4035 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4046 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4242 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4323 | ||
936 | u | w | |d 57 |j 2021 |e 28 |h 3480-3483 |g 4 |
951 | |a AR | ||
952 | |d 57 |j 2021 |e 28 |h 3480-3483 |g 4 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 3924132178 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 06-05-21 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2021 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_5 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_4 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1667350498 |a Englert, Daniel | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416535624 |a Institut für Pharmazie und Molekulare Biotechnologie (IPMB) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_1 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)175724428X |a Matveeva, Regina | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1416822720 |a Extern | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_2 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s p |0 (DE-627)1663703914 |a Sünbül, Murat | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s k |0 (DE-627)1416535624 |a Institut für Pharmazie und Molekulare Biotechnologie (IPMB) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 06 |s s |a pos_3 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s p |0 (DE-627)1440033307 |a Wombacher, Richard | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s k |0 (DE-627)1416822720 |a Extern | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 07 |s s |a pos_4 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s p |0 (DE-627)1439954992 |a Jäschke, Andres | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s k |0 (DE-627)1416535624 |a Institut für Pharmazie und Molekulare Biotechnologie (IPMB) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 08 |s s |a pos_5 |